Frank Leenders

Title: Frank Leenders: Innovator in Biomolecular Technologies

Introduction

Frank Leenders, an accomplished inventor based in Berlin, Germany, has made significant contributions to the field of biomolecular technologies with a total of two patents to his name. His innovative approaches focus on enhancing the functionalities and applications of biomolecules, showcasing his expertise and dedication to scientific advancement.

Latest Patents

Frank's latest patents reflect his cutting-edge work in biomolecular applications. The first patent, titled "Method for the Immobilization of Biomolecules," introduces a novel method for immobilizing biomolecules containing at least one sulfhydryl group. This method involves contacting a modified metal surface with the biomolecule and irradiating the resulting surface with UV radiation in the presence of a photo-initiator. The metal surface is uniquely modified with a cross-linker compound, facilitating effective biomolecule binding.

The second patent, "Multimeric Conjugate," focuses on a multimeric agent and its conjugate formed with a biologically active agent. These multimeric conjugates are designed for improved longevity in vivo and increased avidity compared to unmodified biological agents. This innovation also encompasses pharmaceutical or diagnostic compositions utilizing these conjugates, alongside methods for their production. Moreover, the technology benefits various applications including the detection, determination, separation, isolation of specific binding partners, and contributions to disease diagnosis, prophylaxis, and treatment.

Career Highlights

Throughout his career, Frank Leenders has worked with notable companies that include Celares GmbH and Scil Proteins GmbH. In these roles, he has solidified his standing as a leader in his field, applying his innovative thinking to practical challenges in biomolecular science.

Collaborations

During his professional journey, Frank has collaborated with talented coworkers such as Ralf Kraehmer and Erik Fiedler. These partnerships have allowed for the exchange of ideas and expertise, further driving innovation within their projects.

Conclusion

Frank Leenders' work exemplifies the spirit of innovation in the biomolecular domain. His inventions not only advance scientific understanding but also hold promise for significant applications in pharmaceuticals and diagnostics. As an inventor, he continues to pave the way for future breakthroughs in technology and medicine.